QL
XENE icon

Quarry LP’s Xenon Pharmaceuticals XENE Stock Holding History

Quarry LP’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,500
Closed -$100K – 2691
2025
Q3 		$100K Buy
2,500
+500
+25% +$17.6K 0.02% 539
2025
Q2 		$62.6K Hold
2,000
– – 0.01% 758
2025
Q1 		$67.1K Hold
2,000
– – 0.02% 676
2024
Q4 		$78.4K Buy
+2,000
New +$82.7K 0.02% 540
2024
Q3 		– Sell
-4,000
Closed -$156K – 2145
2024
Q2 		$156K Buy
4,000
+2,700
+208% +$108K 0.07% 215
2024
Q1 		$56K Buy
1,300
+300
+30% +$13.8K 0.02% 414
2023
Q4 		$46.1K Sell
1,000
-3,500
-78% -$124K 0.02% 355
2023
Q3 		$154K Buy
+4,500
New +$168K 0.1% 166

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return